Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Breast Cancer

Asian Patients With HR+, HER2- Breast Cancer Have Higher Recurrence Risk

Asian Patients With HR+, HER2- Breast Cancer Have Higher Recurrence Risk

BY KRISTI ROSA

FDA Approves Pembrolizumab Plus Chemo for TNBC

FDA Approves Pembrolizumab Plus Chemo for TNBC

BY BRIELLE BENYON

A Rundown of New Infusion Therapies

A Rundown of New Infusion Therapies

BY BRIELLE BENYON

Triple-Negative Breast Cancer Treatments Continue to Evolve

Triple-Negative Breast Cancer Treatments Continue to Evolve

BY HAYLEY VIRGIL

Nurses' Role in Cardiotoxicity in Cancer Survivors

Nurses' Role in Cardiotoxicity in Cancer Survivors

BY BRIELLE BENYON

Navigating Breast Cancer Care During a Pandemic

Navigating Breast Cancer Care During a Pandemic

BY CANCERCARE

FDA Advancements in HER2+ Breast Cancer

FDA Advancements in HER2+ Breast Cancer

HER2-targeted Therapy: Routes of Administration

HER2-targeted Therapy: Routes of Administration

BY STAFF

FDA Recommends Black-Box Warning on Breast Implants

FDA Recommends Black-Box Warning on Breast Implants

BY BETH FAND INCOLLINGO

Practical Management of Early Stage HER2+ Breast Cancer

Practical Management of Early Stage HER2+ Breast Cancer

BY STAFF

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.